Swiss Biotech Day

We are proud to sponsor the Swiss Biotech Day, one of Europe’s leading biotechnology conferences. This premier event brings together industry leaders, innovators, and investors to discuss the latest trends and advancements in biotech. Save your ticket here.

Join us at our exclusive panel session on May 6, from 3.00 to 3.45 pm in room MCH Lounge. Together with our experts we will discuss the following topic.

New challenges in Biotech manufacturing and supply chain, how can AI help?

The biotech manufacturing sector is at a pivotal moment, facing challenges that hinder its ability to scale efficiently and maintain consistency. Unlike traditional pharmaceuticals, biotech production relies on complex biological processes, making quality control and scalability particularly demanding. Regulatory frameworks are evolving rapidly, requiring companies to implement robust compliance measures while managing cost pressures. Supply chain vulnerabilities, exacerbated by recent global disruptions, further complicate production and distribution. Failure to address these issues can lead to inconsistent product quality, regulatory setbacks, and limited patient access to critical therapies. However, new technologies such as AI-driven automation and flexible manufacturing platforms offer opportunities to enhance efficiency and resilience. Emerging modalities, including peptides, cell lines and mRNA have specific manufacturing and supply chain challenges, however they continue to attract interest from investors and big pharma alike. Our panel of industry executives will explore these critical challenges and the transformative solutions shaping biotech manufacturing over the next three years.

The session is moderated by Daniel Wilhelm, Managing Director Health Industry Switzerland. Further panelist will be announced soon.